Colonic polyps
Conditions
Interventions
Group A:Early enteral nutrition
Group B:Parenteral nutrition
Sponsors
Sun Yat-Sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Subjects aged from 18 to 75, regardless of gender; 2. Patients with good cardiopulmonary function, normal blood routine and bleeding and clotting time, and can tolerate anesthesia and surgical treatment; 3. Patients with intestinal polyps found by colonoscopy; 4. Patients after endoscopic polypectomy (EMR, ESD); 5. The subjects who can understand the purpose of the experiment voluntarily participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with special types of polyps, such as familial polyposis, etc.; 2. Patients with liver and kidney insufficiency, metabolic acidosis, plasma TG > 200mg / dl, TB > 10mg / dl are not suitable for intravenous nutrition; patients with special nutritional needs (diabetic patients, etc.); 3. Patients with enteral nutrition contraindications, active gastrointestinal bleeding, severe esophageal and gastric varices, intestinal obstruction, abdominal compartment syndrome, acute episode of inflammatory bowel disease, etc.; 4. Subjects with lactose intolerance, milk or soybean allergy; 5. Patients with recent active hemorrhoids bleeding; 6. Patients with poor constitution or other serious diseases, such as myocardial infarction, unstable angina pectoris, stroke or transient ischemic attack (TIA), malignant arrhythmia, heart failure, liver and kidney failure, etc.; 7. Patients who have recently undergone digestive tract surgery such as esophagus, stomach and colorectal surgery; 8. Subjects who were pregnant or planned to be pregnant in the near future; 9. The researchers judged that the subjects with poor compliance did not follow the doctor's advice; 10. Patients who participated in other clinical studies in recent 3 months; 11. Patients with present malignant tumor; 12. Patients taking hormone, immunosuppressant and anticoagulant / antiplatelet drugs within 2 weeks; 13. Patients in other situations considered unsuitable by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative comfort score;Hospital stay;Hospital costs; | — |
Countries
China
Contacts
Public ContactGuoliang Xu
Sun Yat-Sen University Cancer Center
Outcome results
None listed